ライフサイエンス
Overview
Featured News & Insights
0017
連絡先
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort


得意分野
関連リソース
関連公式ブログ
ニュース&インサイト
The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026AI Collaborations – From Strategic License to Strategic AcquisitionJune 10, 2026Medtech Advisory Opinion Highlights Scrutiny of Physician Product Line Royalty ArrangementsJune 9, 2026Boston Life Sciences RoundtableTuesday, June 9, 2026
GoodLifeSci
Technology and Life Sciences Transactions
Global Life Sciences Update
Events
AI Collaborations – From Strategic License to Strategic AcquisitionJune 10, 2026Medtech Advisory Opinion Highlights Scrutiny of Physician Product Line Royalty ArrangementsJune 9, 2026Corporate Practice of Medicine Update: California Attorney General Examines the Friendly Professional Corporation ModelJune 3, 2026DOJ Signals Increasing Scrutiny of Vertically Integrated Healthcare CompaniesJune 3, 2026
Technology and Life Sciences Transactions
Global Life Sciences Update
Healthcare Update
White Collar Defense and Investigations Update
DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 4, 2026Securities Class Actions in the Life Sciences SectorSpring 2026Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market AccessApril 9, 2026FDA's Crackdown On Drug Ads Conflicts With PrecedentApril 2, 2026
Reuters
Publications
Westlaw Today
Law360
Boston Life Sciences RoundtableTuesday, June 9, 2026Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Women’s Life Sciences Network – Biotech Act: Funding and Investment OpportunitiesTuesday, May 19, 2026Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026
Events
Events
Events
Events
Sidley Represents Nourish in US$100 Million Series C FinancingMay 19, 2026Sidley Represents Rigel Pharmaceuticals in Exclusive Global License Agreement with Pfizer and Arvinas for VEPPANUMay 13, 2026Sidley Represents MacroGenics in the Sale of Its GMP Manufacturing OperationsMay 11, 2026Sidley Represents Underwriters in Connection With Pharvaris’ US$115 Million Underwritten Offering of Ordinary SharesMay 8, 2026
Announcements
Announcements
Announcements
Announcements
Sidley Highly Ranked in Chambers USA 2026June 4, 2026Sidley Wins Seven “Firm of the Year” Recognitions at the China Business Law AwardsMay 29, 2026Sidley Wins Three Awards at the Managing IP Americas Awards 2026April 10, 2026Nineteen Sidley Lawyers Named Finalists for the Women in Business Law Americas Awards 2026April 2, 2026
Accolades
Accolades
Accolades
Accolades
The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026EU Pharma Package: Compromise Text Published – Best Efforts Required (Part 2)May 18, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci
Top 10 FDA Areas We Are Watching @ JPM 2026January 12, 2026Renewed Market Optimism @ JPM 2026January 12, 2026What's Ahead for Life Sciences Dealmaking @ JPM 2026January 12, 2026Regulatory Considerations for the Next Wave of Development-Stage Transactions @ JPM 2026January 12, 2026
Videos
Videos
Videos
Videos






































